WALL, N.J., July 20, 2011 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (OTCBB:BKYI), a leader in finger biometric identification solutions, announced the successful deployment by Summa Health System of BIO-key's fingerprint biometrics for compliance with strong authentication as required by the Ohio State Board of Pharmacy.
Summa Health System is one of the largest integrated healthcare delivery systems in Ohio and encompasses a network of hospitals and community-based health centers, a health plan, a physician-hospital organization, an entrepreneurial entity, research and medical education and multiple foundations. Summa is nationally renowned for excellence in patient care and for exceptional approaches to healthcare delivery and represents more than 2,000 licensed, inpatient beds on multiple hospital campuses.
"Our mission is to provide the highest-quality, compassionate care to our patients and to contribute to a healthier community," said Charles Ross, M.D., chief medical information officer at Summa Health System. "Upgrading from our older L-1/Identix fingerprint identification system to BIO-key's solution was fast and easy because we were able to utilize all of the existing Identix biometric fingerprint readers that our staff was already trained and comfortable in using. Also, not having to replace our existing fingerprint readers represented a significant savings to our organization," added Ross.
"BIO-key's solution provides Summa with greater flexibility since we offer complete reader interoperability and as their system evolves and grows, Summa can add fingerprint readers from any of the major fingerprint reader manufacturers that can be used interchangeably with each other and their existing L1-Identix readers," commented Mike DePasquale, CEO of BIO-key International. "Our biometric fingerprint identification complies with the Ohio Pharmacy Board two-factor authentication requirements."
BIO-key offers a compatible and seamless solution for L-1/Identix users seeking to incorporate a biometric element as part of the identification and authentication process. In the case of Summa Health Systems, BIO-key's, Positive ID Director for Allscripts Sunrise Clinical Manager platform as the biometric technology solution. (Allscripts Information Link)
About BIO-key
BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key's award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world's largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key's technology is offered directly or by market leading partners around the world. (http://www.bio-key.com)
About Summa Health System
Summa Health System is one of the largest integrated healthcare delivery systems in Ohio. Encompassing a network of hospitals, community health centers, a health plan, a physician-hospital organization, a multi-specialty physician organization, research and multiple foundations, Summa is nationally renowned for excellence in patient care and for exceptional approaches to healthcare delivery. Summa's clinical services are consistently recognized by the American Nurses Credentialing Center (Magnet status), U.S. News and World Report, Thomson Reuters and The Leapfrog Group. Summa also is a founding partner of the Austen BioInnovation Institute in Akron. For more information, visit www.summahealth.org or find us on Facebook at www.facebook.com/summahealth and Twitter at www.twitter.com/summahealth.
BIO-key Safe Harbor Statement
Certain statements contained in this press release may be construed as "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, and our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2010 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.